IRIS
CONIGLIARO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.430
AS - Asia 3.148
EU - Europa 2.090
SA - Sud America 480
OC - Oceania 58
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 4
Totale 26.261
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.334
SG - Singapore 1.529
CN - Cina 677
HK - Hong Kong 431
BR - Brasile 419
IT - Italia 395
DE - Germania 284
IE - Irlanda 284
RU - Federazione Russa 231
UA - Ucraina 199
FR - Francia 186
GB - Regno Unito 163
VN - Vietnam 158
FI - Finlandia 79
SE - Svezia 69
KR - Corea 65
ID - Indonesia 53
CA - Canada 52
IN - India 47
PL - Polonia 45
NZ - Nuova Zelanda 43
NL - Olanda 35
JP - Giappone 33
TW - Taiwan 33
BE - Belgio 29
MX - Messico 29
AT - Austria 27
AR - Argentina 25
ZA - Sudafrica 24
IR - Iran 19
ES - Italia 18
TR - Turchia 18
BD - Bangladesh 16
AU - Australia 15
EG - Egitto 11
LV - Lettonia 11
EC - Ecuador 10
UZ - Uzbekistan 10
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
MA - Marocco 8
AZ - Azerbaigian 6
IQ - Iraq 6
LT - Lituania 6
DK - Danimarca 5
RO - Romania 5
BG - Bulgaria 4
CH - Svizzera 4
CL - Cile 4
OM - Oman 4
SI - Slovenia 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
PA - Panama 3
PH - Filippine 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
BH - Bahrain 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KW - Kuwait 2
MY - Malesia 2
PE - Perù 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SR - Suriname 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 26.261
Salva come PNG Salva come JPEG
Città #
Wilmington 5.506
Houston 4.791
Woodbridge 4.462
Singapore 672
Fairfield 634
Ann Arbor 527
Ashburn 454
Chandler 426
Hong Kong 420
Dallas 398
Seattle 264
Beijing 261
Dublin 230
Cambridge 212
Medford 175
New York 164
Jacksonville 157
Santa Clara 138
Rome 131
Los Angeles 113
The Dalles 109
Dearborn 87
Lawrence 82
Ho Chi Minh City 64
Zhengzhou 59
São Paulo 57
Moscow 55
Buffalo 54
Redwood City 49
Tauranga 42
London 41
San Diego 36
Munich 35
Jakarta 32
Seoul 31
Chengdu 29
Boardman 28
Kraków 27
Menlo Park 27
Nuremberg 27
Hanoi 26
Toronto 26
Council Bluffs 25
Brussels 24
Nanjing 24
Guangzhou 23
Helsinki 23
Redondo Beach 23
Stockholm 23
Chicago 22
Taipei 22
Shanghai 20
Shenzhen 20
Denver 19
Milan 19
Phoenix 19
Amsterdam 18
Chaozhou 18
Dong Ket 18
Johannesburg 18
Tokyo 18
Warsaw 17
Mülheim 16
Brooklyn 15
Boston 14
Palo Alto 14
Augusta 13
Frankfurt am Main 13
Montreal 13
Norwalk 13
Bassano del Grappa 12
Hefei 12
Lappeenranta 12
Leawood 12
Orem 12
Center 11
Chennai 11
Kunming 11
Mexico City 11
Mountain View 11
San Francisco 11
Brasília 10
Ankara 9
Del Norte 9
Las Vegas 9
North Bergen 9
Poplar 9
Porto Alegre 9
Rio de Janeiro 9
Curitiba 8
Dhaka 8
Mumbai 8
San Mateo 8
Scottsdale 8
Tehran 8
Vienna 8
Atlanta 7
Esslingen am Neckar 7
Manchester 7
San Jose 7
Totale 21.965
Salva come PNG Salva come JPEG
Nome #
Challenges in the treatment of Rheumatoid Arthritis 600
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 510
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 485
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 474
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 472
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 463
Autoantibodies in inflammatory arthritis 459
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 456
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 454
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 447
Characterization of the anticollagen antibody response in a new model of chronic polyarthritis. 445
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 444
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 438
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 437
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. 435
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 430
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 426
The type I IFN system in rheumatoid arthritis 425
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 425
Seronegative autoimmune diseases 420
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 420
Identifying the cells breaching self-tolerance in autoimmunity. 417
Th17 Effector Cells Support B Cell Responses Outside of Germinal Centres 412
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. 407
Lymph node IL-18 expression in adult-onset Still's disease. 406
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 405
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 403
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 400
Insights on the role of physical activity in patients with rheumatoid arthritis 400
Complement, infection, and autoimmunity 400
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 394
The interplay between inflammation and metabolism in rheumatoid arthritis 391
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 383
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate 377
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 377
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation 375
Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. 361
Natural killer and b cells in patients with rheumatoid arthritis and psoriatic arthritis treated with etanercept 346
Histopathology of the skin in rheumatic diseases 346
The complex interplay between rheumatoid arthritis and atopy: Focus on anti-TNFα treatment 342
Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. 338
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 337
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 322
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 318
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 302
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. 293
null 287
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 283
Interaction between microbiome and host genetics in psoriatic arthritis 266
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 253
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 230
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 229
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 227
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 218
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 213
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 213
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 207
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 200
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 197
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 183
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 180
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 173
Severe lupus nephritis: an unexpected association with Fabry disease 163
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 160
Correspondence to ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga and Liew—gender discrepancies at annual EULAR congresses: towards the gap narrowing 155
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 151
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 149
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 141
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 139
COVID-19: disCOVering the role of complement system 139
Gender equality in Rheumatology 138
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 130
Validation of “Clinical Red Flags” for RA-ILD in an Italian cohort 127
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 127
Tackling the autoimmune side in Spondyloarthritis: a systematic review 127
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 118
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 109
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study 88
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 88
Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE 80
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 78
The effects of smoking, alcohol, and dietary habits on the progression and management of spondyloarthritis 78
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 73
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 73
The steroid-sparing effect of JAK inhibitors across multiple patient populations 73
Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren's Syndrome 70
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 68
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 67
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 65
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 63
Alteration of telomere length and mtDNA copy number in interstitial lung disease associated with rheumatoid arthritis 61
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 60
The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors 59
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 58
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 58
Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib 58
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 57
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 55
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population 54
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population 54
Totale 25.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.213
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.073 0 0 0 0 0 498 612 479 186 115 139 44
2021/2022856 37 82 75 58 29 50 40 48 46 66 94 231
2022/20231.178 108 99 40 139 103 259 108 89 116 23 66 28
2023/2024584 60 17 22 15 68 133 15 80 26 19 42 87
2024/20252.880 88 552 366 157 34 260 125 120 228 252 370 328
2025/20262.947 380 400 847 666 545 109 0 0 0 0 0 0
Totale 26.744